License agreement provides Jumpcode Genomics access to CRISPR gene editing technology to enhance next-generation sequencing capabilities DUBLIN and SAN DIEGO — ERS Genomics Limited (‘ERS’), the CRISPR licensing company, and Jumpcode Genomics (‘Jumpcode’), a life science tools company improving and reducing the cost of next-generation sequencing technology, today announced a non-exclusive CRISPR/Cas9 license agreement. The agreement grants Jumpcode access […]

Cambridge, UK and Wuxi, China – SPT Labtech, a renowned multinational innovator specializing in automated instrumentation and consumables, joined forces with Biortus Biosciences Co., Ltd., a global leader in integrated capabilities spanning from gene to structural analysis, to inaugurate their strategic partnership and unveil the “Joint Laboratory of Structural Biology” at I-Campus. This collaboration marks […]

BC Platforms is a partner in BRECISE (Biomarker Research and Evaluation for Clinical Implementation and Supporting Systems Enhancement), a five-year multidisciplinary research initiative co-funded by the Innovative Health Initiative (IHI) under the Horizon Europe programme. The project officially launched in Madrid on March 20, 2025, and runs from January 1, 2025, through 2029. What Is […]

SAN JOSE, Calif. – Complete Genomics, a leading innovator in genomic sequencing, announced at the NextGen Omics & Spatial Biology Conference that it has partnered with BioTuring, developer of advanced bioinformatics algorithms and software that enables rapid OMICS analysis, to offer researchers access to SpatialX, a powerful deep-learning tool for unified multi-technology spatial data analysis compatible with STOmics chemistries designed to […]

BOSTON — Leveragen Inc., a Boston-based biotechnology company specializing in next-generation genetic models for antibody discovery, today announced a comprehensive collaboration with Cell Signaling Technology (CST), a global leader in high-quality research antibodies and associated reagents. This collaboration will explore Leveragen’s proprietary Singularity Musculus platform to expedite the development of mouse-derived nanobodies tailored for reagent antibody […]

SAN JOSE, Calif. – Complete Genomics, a leading innovator in genomic sequencing, announced at the NextGen Omics & Spatial Biology Conference that it has entered a commercial partnership with Human Cell Atlas (HCA) to offer its STOmics spatial transcriptomics products to HCA members. Human Cell Atlas (HCA), an international collaborative research consortium, is mapping all cell types in the […]

AlidaBio EpiPlex™ customers now have cloud access to the EpiScout™ analysis software on DNAnexus’ secure, scalable precision health data cloud platform MOUNTAIN VIEW, Calif. — DNAnexus, provider of the leading enterprise platform for precision health data, and Alida Biosciences (AlidaBio), a leader in RNA epigenomic research tools, today announced a strategic collaboration designed to accelerate discovery and […]

On February 21, Shimadzu Scientific Korea Corporation (SSK), a subsidiary of Shimadzu in South Korea, and Chungnam National University signed a memorandum of understanding (MOU) with the objectives of strengthening the development of technology and research equipment, and promoting collaborative research between industry and academia. Chungnam National University, which was established in 1952 in Daejeon […]

The SAGC joins Parse’s network to meet rising demand for high-quality single cell solutions in Australia SEATTLE — Parse Biosciences, the leader in scalable and accessible single cell sequencing, is pleased to welcome the South Australian Genomics Centre (SAGC) as the newest member of its Certified Service Provider (CSP) Program. As a certified provider, the SAGC expands […]

Fremont, CA – Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is pleased to announce the signing of five new distribution partners to expand its global presence. The company has partnered with established industry leaders across key international markets to enhance access to its innovative proteomics technologies. The newly […]